However, despite GLP-1 agonists higher efficacy, the higher cost makes them not cost-effective [61] in some analyses when compared to older, less expensive alternatives
In summary, while both Retatrutide and Tirzepatide are highly effective for weight loss, Retatrutides triple agonism and superior clinical trial results make it a potentially more powerful option for patients seeking significant weight loss.
The combination addresses separate metabolic pathways semaglutide reduces caloric intake, Lipo B optimises fat oxidation but the effect is complementary, not synergistic
March 2026 Generic semaglutide entered the Indian market in March 2026
But when you look at a thousand studies, and then you try it out, and then you understand some metabolic pathways, and you hypothesize, and then you test, and you look at the results, the name for that is science
Tweak diet, supplement dose, or introduce targeted therapy if markers stay elevated